Abstract:This study by Langton et al 1 explores the association between maternal family history and the development of uterine fibroids among a cohort of Black women who were fibroid-free at baseline. By ascertaining maternal fibroid history through direct surveying of the mothers, Langton et al 1 provide a more robust assessment of family history of fibroids than has been captured previously using variable methods. Despite this enhanced method, this investigation by Langton et al 1 offers a critical example of how structural racism intersects with health services delivery that affects the fundamental epidemiologic understanding of a medical condition disproportionately experienced by Black women. At its most essential level, the field of epidemiology involves the counting of incident occurrences of a disease or health outcome. However, for conditions like uterine fibroids, the counting of cases cannot be isolated from the systemically racist history of reproductive health care in the US. 2 The field of obstetrics and gynecology has its origins in the exploitation of and experimentation on Black and poor women, with the vestiges of this troubled legacy impacting gynecologic care delivery today. 3 By modern standards, Black women have less access to high-quality reproductive health care, which can influence the detection and diagnosis of gynecologic conditions, like uterine fibroids. When diagnosed, Black women are known to have higher incidence rates of uterine fibroids than other women and are more likely to be diagnosed at younger ages. 4 ,5 Prior work has qualitatively and quantitatively described experiences of racial discrimination and dismissal of symptoms among Black women with uterine fibroids. 6 In their study, Langton et al 1 found that having a positive maternal history of fibroids greatly increased the risk of incident fibroid development in adult daughters. Importantly, Langton et al 1 also found that 24% of potential participants entering the cohort believed themselves to be fibroid-free but were found to have fibroids in ultrasonographic examination. Therefore, while directly surveying the mothers represents an improvement over prior family history methods, it likely remains an underestimation of true maternal disease burden that exists. The presence of a mother reporting a fibroids diagnosis represents a particularly high level of access to health care that emphasizes the complex associations between health care delivery and epidemiology for conditions like uterine fibroids. While the detection of fibroids on cohort entry was incidental to the main study findings, 1 it highlights the substantial underdiagnosis of uterine fibroids in Black women, which may suggest an overall underascertainment of the magnitude of racial inequities that exist for uterine fibroids at a population level. 7 When considering the epidemiologic burden of disease, it must be interrogated whether the absence of a diagnosis truly reflects the absence of a disease. In understanding the population-level burden of disease for conditions like uterine fibroids we must ask ourselves who, and what counts? Epidemiology does not exist in a sociopolitical vacuum, underscoring the need for multiple domains of expertise in characterizing disease burden. Published: April 3, 2024. doi:10.1001/jamanetworkopen.2024.4165 Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2024 Roberson ML. JAMA Network Open . Corresponding Author: Mya L. Roberson, MSPH, PhD, Gillings School of Global Public Health, Department of Health Policy and Management, University of North Carolina at Chapel Hill, 1106B McGavran Greenberg Hall, 135 Dauer Dr, CB#7411, Chapel Hill, NC 27599-7411 (Mya_Roberson@unc.edu). Conflict of Interest Disclosures: None reported.

"I think people should be more aware:" Uterine fibroid experiences among women living in Indiana, USA

A Call-to-Action for Clinicians to Implement Evidence-Based Best Practices When Caring for Women with Uterine Fibroids

Beyond the physical: a qualitative assessment of the burden of symptomatic uterine fibroids on women's emotional and psychosocial health

173 Delving into Sociocultural Influences in Access to Care in Black Women and Latinas with Uterine Fibroids

Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women

82913 Engaging women of color virtually: Cultural Impact of Treatment Delays among Women of Color with Uterine Fibroids

Epidemiology and management of uterine fibroids

"In our community, we normalize pain": discussions around menstruation and uterine fibroids with Black women and Latinas

Assessing burden, risk factors, and perceived impact of uterine fibroids on women’s lives in rural Haiti: implications for advancing a health equity agenda, a mixed methods study

A plain language summary of the perspectives of women who were interviewed about their experiences with uterine fibroids

The power of proximity: Effects of a multidisciplinary fibroid clinic on inter-specialty perceptions and practice patterns

Study protocol for the implementation of Centering Patients with Fibroids, a novel group education and empowerment program for patients with symptomatic uterine fibroids

Exploring uterine fibroids and its treatment in current scenario

Structural Racism, Health Services Research, and Burden of Uterine Fibroids

Uterine Fibroids “Spectrum of Presentation and Its Impact on Women’s Health

Epidemiological study of uterine fibroids: our experience from urban Maharashtra

Diagnosis and management of uterine fibroids: current trends and future strategies

The impact of Fibroid Treatments on Quality of Life and Mental Health: A Systematic Review

Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study

Uterine fibroids — Causes, impact, treatment, and lens to the African perspective

Uterine fibroid management: from the present to the future